Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.

Abstract

British Journal of Clinical PharmacologyVolume 7, Issue 4 p. 401-403 Free Access Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol. JA Steiner, JA SteinerSearch for more papers by this authorR Cooper, R CooperSearch for more papers by this authorJS Gear, JS GearSearch for more papers by this authorJG Ledingham, JG LedinghamSearch for more papers by this author JA Steiner, JA SteinerSearch for more papers by this authorR Cooper, R CooperSearch for more papers by this authorJS Gear, JS GearSearch for more papers by this authorJG Ledingham, JG LedinghamSearch for more papers by this author First published: April 1979 https://doi.org/10.1111/j.1365-2125.1979.tb00953.xCitations: 17AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Brick, I., Glover, W.E., Hutchison, K.J. & Roddie, I.C. (1966). Effects of propranolol on peripheral vessels in man. Am. J. Cardiol., 18, 329– 332. Farmer, J.B., Kennedy, I., Levy, G.P. & Marshall, R.J. (1972). Pharmacology of AH 5158; a drug which blocks both α- and β-adrenoceptors. Br. J. Pharmac., 45, 660– 675. Imms, F.J., Neame, R.L.B. & Powis, D.A. (1977). Responses of the cardiovascular system of the rat to noradrenaline infusions and their modification by adrenoceptor blocking agents. Br. J. Pharmac., 60, 115– 122. Johnsson, G. (1967). The effects of intra-arterially administered propranolol and H 56/28 on blood flow in the forearm—a comparative study of two β-adrenergic receptor antagonists. Acta pharmac. tox., 25, suppl. 2, 63– 74. Lund-Johansen, P. (1973). Haemodynamic changes in long-term therapy of essential hypertension: a comparative study of diuretics, α-methyldopa and clonidine. Clin. Sci. mol. Med., 45, 199S– 203S. Lundvall, V. & Järhult, J. (1976). Beta adrenergic dilator component of the sympathetic vascular response in skeletal muscle. Influence on the micro-circulation and on transcapillary exchange. Acta physiol. Scand., 96, 180– 192. Marshall, A.J., Roberts, C.J.C. & Barritt, D.W. (1976). Raynaud's phenomenon as side effect of beta-blockers in hypertension. Br. med. J., 1, 1498– 1499. McGrath, M. & Penny, R. (1974). The mechanisms of Raynaud's phenomenon: part I. Med. J. Aust., 2, 328– 333. McGrath, M.A., Peek, R. & Penny, R. (1978). Raynaud's disease: reduced hand blood flow with normal blood viscosity. Aust. N.Z. J. Med., 8, 126– 131. Peacock, J.H. (1960). The effect of changes in local temperature on the blood flows of the normal hand, primary Raynaud's disease and primary acrocyanosis. Clin. Sci., 19, 505– 512. Richards, D.A. (1976). Pharmacological effects of labetalol in man. Br. J. clin. Pharmac., 3, (4 suppl. 3), 721– 723. Zacharias, F.J., Cowen, K.J., Prestt, J., Vickers, J. & Wall, B.G. (1972). Propranolol in hypertension: a study of long-term therapy, 1964–1970. Am. Heart J., 83, 755– 761. Citing Literature Volume7, Issue4April 1979Pages 401-403 ReferencesRelatedInformation